Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01867372 · ClinicalTrials.gov registry record

Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes

A clinical trial, sponsored by National Institute on Aging (NIA).

Terminated
Registry status
213
Enrollment target

NCT01867372 is a clinical trial that was terminated before completion, run by National Institute on Aging (NIA). The registered enrollment target is 213 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01867372 was terminated before completion, sponsored by National Institute on Aging (NIA).

TERMINATED
Registry status
213 participants
Enrollment target

Study Summary

Background: \- Participants in the Baltimore Longitudinal Study of Aging are being studied to examine changes in brain structure and function over time, and to determine if these changes can predict the likelihood that an individual will develop thinking and memory impairments such as Alzheimer s disease later in life. Imaging studies and neuropsychological testing have been conducted on current participants, and new participants are being recruited to the study. To develop better treatments and therapies for aging-related memory loss and other disorders, researchers are interested in determining whether early prediction of thinking and memory impairments are accurate and in evaluating factors that affect these predictions. Objectives: \- To use imaging studies and tests of thinking and memory to determine early markers of Alzheimer s disease and other cognitive impairments. Eligibility: \- Current participants and new recruits to the Baltimore Longitudinal Study of Aging. Design: * Participants will be screened with a full medical history and physical examination, as well as blood and urine tests. * Participants will have testing visits as directed by the study researchers. All participants will have tests as part of their an initial enrollment in the study, and may be asked to return yearly, 2 years later, or 4 years later for repeated tests. * At each visit, participants will have brain imaging scans (including magnetic resonance imaging and/or magnetic resonance spectroscopy to measure brain structure and function, and positron emission tomography to study blood flow in the brain) to evaluate brain structure and function. Participants will also take tests of memory and problem-solving skills. * Treatment will not be provided as part of this protocol.

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 2003-03-10
Est. Completion 2014-09-22

Sponsor

National Institute on Aging (NIA)

131 total trials

What the Registry Record Tells You About NCT01867372

The ClinicalTrials.gov registry entry for NCT01867372 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01867372 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01867372 about?

NCT01867372 is a clinical study titled "Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes". Background: \- Participants in the Baltimore Longitudinal Study of Aging are being studied to examine changes in brain structure and function over time, and to determine if these changes can predict the likelihood that an individual will develop thinking and memory impairments such as Alzheimer s d...

What is the current status of trial NCT01867372?

This trial is currently terminated. The enrollment target is 213 participants. The study started on 2003-03-10. Estimated completion is 2014-09-22.

Who is sponsoring clinical trial NCT01867372?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.